Pooja Mittal Selected Research

Premature Obstetric Labor (Premature Labor)

10/2010	Pentraxin 3 in maternal circulation: an association with preterm labor and preterm PROM, but not with intra-amniotic infection/inflammation.
9/2010	Evidence for a spatial and temporal regulation of prostaglandin-endoperoxide synthase 2 expression in human amnion in term and preterm parturition.
2/2010	Adiponectin in amniotic fluid in normal pregnancy, spontaneous labor at term, and preterm labor: a novel association with intra-amniotic infection/inflammation.
1/2010	Evidence for differential regulation of the adipokine visfatin in the maternal and fetal compartments in normal spontaneous labor at term.
11/2009	Changes in amniotic fluid concentration of thrombin-antithrombin III complexes in patients with preterm labor: evidence of an increased thrombin generation.
11/2009	Evidence for complement activation in the amniotic fluid of women with spontaneous preterm labor and intra-amniotic infection.
10/2009	Dysregulation of maternal serum adiponectin in preterm labor.
8/2009	Maternal plasma visfatin in preterm labor.
5/2009	Amniotic fluid fetal hemoglobin in normal pregnancies and pregnancies complicated with preterm labor or prelabor rupture of membranes.
1/2009	Amniotic fluid angiopoietin-2 in term and preterm parturition, and intra-amniotic infection/inflammation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pooja Mittal Research Topics

Disease

28	Inflammation (Inflammations) 01/2023 - 11/2007
25	Infections 01/2022 - 01/2008
19	Pre-Eclampsia (Preeclampsia) 07/2018 - 10/2006
16	Premature Obstetric Labor (Premature Labor) 10/2010 - 01/2008
7	Neoplasms (Cancer) 10/2023 - 03/2017
7	Chorioamnionitis 11/2011 - 07/2008
6	Fetal Death 11/2011 - 08/2009
6	Pyelonephritis 10/2010 - 11/2007
6	Overweight 03/2010 - 01/2009
5	Breast Neoplasms (Breast Cancer) 10/2023 - 01/2018
5	Insulin Resistance 02/2010 - 12/2008
4	Rupture 08/2010 - 01/2008
4	Preterm Premature Rupture of the Membranes 12/2009 - 10/2008
3	Wounds and Injuries (Trauma) 12/2019 - 11/2018
3	Premature Birth (Birth, Premature) 03/2011 - 06/2007
3	Birth Weight (Birth Weights) 03/2010 - 01/2009
3	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2010 - 01/2009
3	Obesity 01/2009 - 12/2008
2	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2024 - 01/2023
2	Hypersensitivity (Allergy) 08/2023 - 03/2019
2	Parkinson Disease (Parkinson's Disease) 06/2023 - 01/2023
2	Hypoxia (Hypoxemia) 08/2011 - 02/2011
2	Sepsis (Septicemia) 03/2010 - 02/2010
2	Pregnancy Complications 12/2009 - 08/2009
2	Diabetes Mellitus 01/2009 - 01/2009
1	Celiac Disease (Celiac Sprue) 08/2023
1	Neuroinflammatory Diseases 01/2023
1	Huntington Disease (Huntington's Disease) 01/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Chronic Periodontitis 07/2022
1	COVID-19 10/2021
1	Lymphoma (Lymphomas) 09/2021
1	Leukemia 09/2021
1	Starvation 04/2020
1	Hemolysis 01/2020

Drug/Important Bio-Agent (IBA)

10	AdipokinesIBA 03/2010 - 12/2008
8	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2009
8	Nicotinamide PhosphoribosyltransferaseIBA 10/2010 - 01/2008
6	ChemokinesIBA 11/2010 - 11/2007
6	CytokinesIBA 11/2010 - 09/2008
6	AdiponectinIBA 02/2010 - 01/2009
5	Thrombin FDA Link 07/2018 - 06/2008
5	N 30IBA 11/2011 - 07/2008
5	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2010 - 02/2010
4	AntioxidantsIBA 06/2023 - 08/2019
4	Complement System Proteins (Complement)IBA 11/2010 - 10/2008
3	MicroRNAs (MicroRNA)IBA 01/2023 - 03/2007
3	AntibodiesIBA 11/2011 - 09/2008
3	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 12/2010 - 10/2006
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2010 - 11/2009
3	InterleukinsIBA 11/2010 - 09/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2010 - 11/2009
3	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 08/2010 - 10/2006
2	Neuroprotective AgentsIBA 05/2024 - 01/2023
2	HLA Antigens (Human Leukocyte Antigens)IBA 08/2023 - 12/2009
2	PhytochemicalsIBA 01/2023 - 10/2021
2	LipidsIBA 01/2023 - 01/2019
2	Peptide Hydrolases (Proteases)FDA Link 04/2020 - 06/2008
2	Lapatinib (GW572016)FDA Link 01/2020 - 01/2018
2	QuercetinIBA 12/2019 - 08/2019
2	Free RadicalsIBA 12/2019 - 11/2018
2	Ciprofloxacin (Cipro)FDA LinkGeneric 12/2019 - 08/2019
2	Hydroxyproline (4 Hydroxyproline)IBA 08/2019 - 11/2018
2	Thromboplastin (Tissue Factor)IBA 06/2018 - 08/2009
2	Interleukin-6 (Interleukin 6)IBA 03/2011 - 02/2011
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2011 - 11/2010
2	PTX3 proteinIBA 10/2010 - 01/2010
2	EndoglinIBA 08/2010 - 02/2010
2	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 02/2010 - 01/2010
2	Antithrombin IIIIBA 11/2009 - 08/2009
2	Hemostatics (Antihemorrhagics)IBA 11/2009 - 08/2009
2	Protein Isoforms (Isoforms)IBA 10/2009 - 01/2009
2	plasma protein Z (protein Z)IBA 08/2009 - 09/2008
2	Hemoglobins (Hemoglobin)IBA 05/2009 - 10/2008
2	Furylfuramide (AF2)IBA 11/2008 - 01/2008
1	Silybin (Lagosa)IBA 10/2023
1	HLA-DQ8 antigenIBA 08/2023
1	Glutens (Glutelin)IBA 08/2023
1	engeletinIBA 01/2023
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2023
1	Doxycycline (Periostat)FDA LinkGeneric 07/2022
1	PolymersIBA 07/2022
1	GlucansIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	FlavonoidsIBA 01/2022
1	TriterpenesIBA 01/2022
1	Polysaccharides (Glycans)IBA 01/2022
1	MicronutrientsIBA 01/2022
1	VitaminsIBA 10/2021
1	Oncogene Proteins (Oncogene Protein)IBA 09/2021
1	UCON 50-HB-5100 (F127)IBA 01/2020
1	MicellesIBA 01/2020
1	CollagenIBA 12/2019
1	GelatinIBA 08/2019
1	CatalaseIBA 08/2019
1	cremophor ELIBA 03/2019

Therapy/Procedure

6	Therapeutics 10/2023 - 01/2019
1	Root Planing 07/2022
1	Intravenous Administration 01/2020